Ute Spiekerkoetter1, Heiko Krude. 1. General Pediatrics, Adolescent Medicine and Neonatology, University Medical Center, Medical Faculty, University of Freiburg; Institute of Experimental Pediatric Endocrinology, Charité-University Medical Center Berlin.
Abstract
BACKGROUND: Neonatal screening in Germany currently comprises 19 congenital diseases, 13 of which are metabolic diseases. Approximately one in 1300 newborns suffers from one of these target diseases. Early diagnosis and treatment enable the affected children to undergo better development and even, in many cases, to have a normal life. METHODS: This review is based on pertinent publications retrieved by a selective search in the PubMed and Embase databases. RESULTS: Positive screening findings are confirmed in approximately one out of five newborns. The prompt evaluation of suspected diagnoses is essential, as treatment for some of these diseases must be initiated immediately after birth to prevent longterm sequelae. The most commonly identified diseases are primary hypothyroidism (1:3338), phenylketonuria/hyperphenylalaninemia (1 : 5262), cystic fibrosis (1 : 5400), and medium-chain acyl-CoA dehydrogenase deficiency (1 : 10 086). Patient numbers are rising as new variants of the target diseases are being identified, and treatments must be adapted to their heterogeneous manifestations. Precise diagnosis and the planning of treatment, which is generally lifelong, are best carried out in a specialized center. CONCLUSION: Improved diagnosis and treatment now prolong the lives of many patients with congenital diseases. The provision of appropriate long-term treatment extending into adulthood will be a central structural task for screening medicine in the future.
BACKGROUND: Neonatal screening in Germany currently comprises 19 congenital diseases, 13 of which are metabolic diseases. Approximately one in 1300 newborns suffers from one of these target diseases. Early diagnosis and treatment enable the affected children to undergo better development and even, in many cases, to have a normal life. METHODS: This review is based on pertinent publications retrieved by a selective search in the PubMed and Embase databases. RESULTS: Positive screening findings are confirmed in approximately one out of five newborns. The prompt evaluation of suspected diagnoses is essential, as treatment for some of these diseases must be initiated immediately after birth to prevent longterm sequelae. The most commonly identified diseases are primary hypothyroidism (1:3338), phenylketonuria/hyperphenylalaninemia (1 : 5262), cystic fibrosis (1 : 5400), and medium-chain acyl-CoA dehydrogenase deficiency (1 : 10 086). Patient numbers are rising as new variants of the target diseases are being identified, and treatments must be adapted to their heterogeneous manifestations. Precise diagnosis and the planning of treatment, which is generally lifelong, are best carried out in a specialized center. CONCLUSION: Improved diagnosis and treatment now prolong the lives of many patients with congenital diseases. The provision of appropriate long-term treatment extending into adulthood will be a central structural task for screening medicine in the future.
Authors: Melanie B Gillingham; Stephen B Heitner; Julie Martin; Sarah Rose; Amy Goldstein; Areeg Hassan El-Gharbawy; Stephanie Deward; Michael R Lasarev; Jim Pollaro; James P DeLany; Luke J Burchill; Bret Goodpaster; James Shoemaker; Dietrich Matern; Cary O Harding; Jerry Vockley Journal: J Inherit Metab Dis Date: 2017-09-04 Impact factor: 4.982
Authors: U Spiekerkoetter; M Lindner; R Santer; M Grotzke; M R Baumgartner; H Boehles; A Das; C Haase; J B Hennermann; D Karall; H de Klerk; I Knerr; H G Koch; B Plecko; W Röschinger; K O Schwab; D Scheible; F A Wijburg; J Zschocke; E Mayatepek; U Wendel Journal: J Inherit Metab Dis Date: 2009-04-29 Impact factor: 4.982
Authors: Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White Journal: Endocr Rev Date: 2022-01-12 Impact factor: 19.871
Authors: Michael Pugliese; Kylie Tingley; Andrea Chow; Nicole Pallone; Maureen Smith; Alvi Rahman; Pranesh Chakraborty; Michael T Geraghty; Julie Irwin; Laure Tessier; Stuart G Nicholls; Martin Offringa; Nancy J Butcher; Ryan Iverson; Tammy J Clifford; Sylvia Stockler; Brian Hutton; Karen Paik; Jessica Tao; Becky Skidmore; Doug Coyle; Kathleen Duddy; Sarah Dyack; Cheryl R Greenberg; Shailly Jain Ghai; Natalya Karp; Lawrence Korngut; Jonathan Kronick; Alex MacKenzie; Jennifer MacKenzie; Bruno Maranda; John J Mitchell; Murray Potter; Chitra Prasad; Andreas Schulze; Rebecca Sparkes; Monica Taljaard; Yannis Trakadis; Jagdeep Walia; Beth K Potter Journal: Orphanet J Rare Dis Date: 2020-01-14 Impact factor: 4.123
Authors: Eva M M Hoytema van Konijnenburg; Saskia B Wortmann; Marina J Koelewijn; Laura A Tseng; Roderick Houben; Sylvia Stöckler-Ipsiroglu; Carlos R Ferreira; Clara D M van Karnebeek Journal: Orphanet J Rare Dis Date: 2021-04-12 Impact factor: 4.123
Authors: Frank ter Veld; Martina Mueller; Simone Kramer; Ulrike Haussmann; Diran Herebian; Ertan Mayatepek; Maurice D Laryea; Sonja Primassin; Ute Spiekerkoetter Journal: PLoS One Date: 2009-07-30 Impact factor: 3.240